Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
39 studies found for:    hemochromatosis
Show Display Options
RSS Create an RSS feed from your search for:
hemochromatosis
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Treatment of Hemochromatosis
Condition: Hemochromatosis
Intervention:
2 Recruiting Impact of Bloodletting on Iron Metabolism in Type 1 Hemochromatosis
Condition: Hemochromatosis Type 1
Intervention: Procedure: First evaluation phase : no intervention / Second evaluation phase: bloodletting of 7 ml/kg (with a maximum of 500ml)
3 Unknown  Erythrocyte Apheresis Versus Phlebotomy in Hemochromatosis
Condition: Hemochromatosis
Interventions: Procedure: Arm 1: Erythrocyte apheresis;   Procedure: Arm 2: Whole blood phlebotomy
4 Completed Bone Status on Patients With Genetic Hemochromatosis: a 3 Years Descriptive and Evolutionary Study
Condition: Genetic Hemochromatosis
Intervention:
5 Active, not recruiting Cardiac Function in Patients With Hereditary Hemochromatosis
Condition: Hemochromatosis
Intervention:
6 Completed Haemochromatosis:Phlebotomy Versus Erythrocytapheresis Therapy
Condition: Hemochromatosis
Interventions: Procedure: Phlebotomy;   Procedure: Erythrocytapheresis
7 Unknown  Erythrocytapheresis Versus Phlebotomy as Maintenance Therapy in Hereditary Hemochromatosis (HH) Patients
Condition: Hereditary Hemochromatosis
Intervention: Other: Phlebotomy and erythrocytapheresis
8 Unknown  Proton Pump Inhibitors in the Prevention of Iron Reaccumulation in Patient With Hereditary Hemochromatosis
Condition: Hemochromatosis
Intervention: Drug: Pantoprazole
9 Completed HEPFER-Evaluation of a New Phenotypic Biological Marker in Genetic Type 1 Hemochromatosis
Condition: Hereditary Hemochromatosis C282Y Homozygous
Intervention:
10 Completed Clinical Management of Hereditary Hemochromatosis: Phlebotomy vs. Erythrocytoapheresis
Condition: Hereditary Hemochromatosis
Intervention: Procedure: Eritrocytoapheresis
11 Unknown  Implications for Quality of Life and Quality of Care in Patients With Hereditary Haemochromatosis
Condition: Hereditary Haemochromatosis
Intervention: Other: Interviews, questionaires, RAND-modified delphi method round
12 Recruiting Treatment of Refractory Hemochromatosis Rheumatism by Anakinra: a Preliminary Phase II Study
Condition: Refractory Hemochromatosis Rheumatism
Intervention: Drug: Anakinra
13 Completed
Has Results
Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis
Conditions: Iron Overload;   Hereditary Hemochromatosis
Intervention: Drug: Deferasirox (ICL670)
14 Recruiting Estimation of Myocardial Iron Overload by 3 Tesla MRI in HFE Hereditary Haemochromatosis
Conditions: Myocardial Iron Overload;   HFE-Associated Hereditary Hemochromatosis
Interventions: Device: 3Tesla cardiac MRI;   Device: Electrocardiogram (EKG);   Biological: Iron and cardiac markers;   Biological: Pregnancy test;   Device: Echocardiography at rest;   Biological: Urinary pregnancy test;   Device: 3Tesla abdominal MRI
15 Unknown  Treatment of Iron Overload With Deferasirox (Exjade) in Hereditary Hemochromatosis and Myelodysplastic Syndrome
Conditions: Hemochromatosis;   Myelodysplastic Syndromes
Interventions: Drug: Deferasirox;   Other: Venesection
16 Completed Evaluation of a New MR Pulse Sequence to Quantify Liver Iron Concentration
Condition: Hemochromatosis
Intervention:
17 Completed Study With Deferiprone and/or Desferrioxamine in Iron Overloaded Patients
Condition: Hemochromatosis
Interventions: Drug: Deferiprone (L1);   Drug: Desferrioxamine
18 Completed Hemochromatosis--Genetic Prevalence and Penetrance
Conditions: Blood Disease;   Hemochromatosis
Intervention:
19 Completed Statistical Basis for Hemochromatosis Screening
Conditions: Blood Disease;   Hemochromatosis
Intervention:
20 Completed Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent Patients
Condition: Hemochromatosis
Interventions: Drug: Deferiprone (L1);   Drug: Desferrioxamine

   Previous Page Studies Shown (1-20) Next Page (21-39) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.